» Articles » PMID: 20940193

Screening for Distress in Lung and Breast Cancer Outpatients: a Randomized Controlled Trial

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2010 Oct 14
PMID 20940193
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Distress has been recognized as the sixth vital sign in cancer care and several guidelines recommend routine screening. Despite this, screening for distress is rarely conducted and infrequently evaluated.

Methods: A program of routine online screening for distress was implemented for new patients with breast and lung cancer. Patients were randomly assigned to one of three conditions: (1) minimal screening: the distress thermometer (DT) only plus usual care; (2) full screening: DT, problem checklist, Psychological Screen for Cancer part C measuring anxiety and depression, a personalized report summarizing concerns and the report on the medical file; or (3) triage: full screening plus optional personalized phone triage with referral to resources. Patients in all conditions received an information packet and were reassessed 3 months later with the full screening battery.

Results: Five hundred eighty-five patients with breast cancer and 549 patients with lung cancer were assessed at baseline (89% of all patients), and 75.5% retained for follow-up. High prevalence of baseline distress was found across patients. Twenty percent fewer patients with lung cancer in triage continued to have high distress at follow-up compared to those in the other two groups, and patients with breast cancer in the full screening and triage conditions showed lower distress at follow-up than those in minimal screening. The best predictor of decreased anxiety and depression in full screening and triage conditions was receiving a referral to psychosocial services.

Conclusion: Routine online screening is feasible in a large cancer center and may help to reduce future distress levels, particularly when coupled with uptake of appropriate resources.

Citing Articles

A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?.

Cherny N, Nortje N, Kelly R, Zimmermann C, Jordan K, Kreye G ESMO Open. 2025; 10(1):104099.

PMID: 39765188 PMC: 11758828. DOI: 10.1016/j.esmoop.2024.104099.


The association of distress and depression screening measures and other electronic health record information with adjuvant endocrine therapy persistence.

Neuner J, Stolley M, Kamaraju S, Tiegs J, Sparapani R, Makris V Breast Cancer Res Treat. 2024; 209(3):541-552.

PMID: 39592520 DOI: 10.1007/s10549-024-07513-5.


Nurse-Led Screening-Triggered Early Specialized Palliative Care Program for Patients With Advanced Lung Cancer: A Multicenter Randomized Controlled Trial.

Matsumoto Y, Umemura S, Okizaki A, Fujisawa D, Yamaguchi T, Oyamada S Cancer Med. 2024; 13(22):e70325.

PMID: 39556485 PMC: 11572738. DOI: 10.1002/cam4.70325.


A mixed method feasibility and acceptability study of a flexible intervention based on acceptance and commitment therapy for patients with cancer.

Bourgognon F, Bechet D, Huin-Schohn C, Strelow A, Demarche L, Guillou M Front Psychol. 2024; 15:1409308.

PMID: 39021646 PMC: 11252038. DOI: 10.3389/fpsyg.2024.1409308.


Usability and Preliminary Efficacy of an Adaptive Supportive Care System for Patients With Cancer: Pilot Randomized Controlled Trial.

Baik S, Clark K, Sanchez M, Loscalzo M, Celis A, Razavi M JMIR Cancer. 2024; 10:e49703.

PMID: 38986134 PMC: 11269963. DOI: 10.2196/49703.